The FDA approval of Halaven was based on the results of the phase III EMBRACE clinical trials.
-
Halaven contains an antineoplastic agent that is called eribulin. -
The drug is derived from marine sponge natural product Halichondrin B. -
The drug suppresses the growth of microtubules. -
The FDA approval of Halaven was based on the results of the phase III EMBRACE...
